‘Closed for COVID-19:’ Receiving a Cancer Diagnosis at the Start of COVID-19
FDA Grants Accelerated Approval to Enhertu for Subgroup of Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
Use of Potentially Inappropriate Medications Associated With Increased Risks for Poor Outcomes in Older Patients With Cancer
FDA Grants Tabrecta a Regular Approval for Certain Patients With Lung Cancer